Protagenic Therapeutics, Inc.\new (PTIX) Return on Equity [ROE] (2016 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Return on Equity [ROE] of 251.57% for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 957.95 percentage points from the prior quarter.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Return on Equity [ROE] (2016 - 2026) Analysis & Trends
For FY2024 (ended Dec 31, 2024), Protagenic Therapeutics, Inc.\new's Return on Equity [ROE] came in at -3157.38%, down 3062.91 percentage points from FY2023.
- Annual Return on Equity [ROE] shows a three-year change of -3054.50 percentage points (FY2021 to FY2024).
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Return on Equity [ROE] was -94.48% in FY2023 (-52.30 pp), -42.18% in FY2022 (+60.71 pp) and -102.88% in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | - |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 4.97% |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - | 251.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 251.57% |
| Mar 31, 2026 | 1,209.51% |
| Mar 31, 2024 | -639.37% |
| Dec 31, 2023 | -127.88% |
| Sep 30, 2023 | -82.07% |
| Jun 30, 2023 | -58.41% |
| Mar 31, 2023 | -43.68% |
| Dec 31, 2022 | -49.73% |
| Sep 30, 2022 | -49.16% |
| Jun 30, 2022 | -44.74% |
| Mar 31, 2022 | -50.14% |
| Sep 30, 2021 | -1,944.24% |
| Jun 30, 2021 | -98.10% |
| Dec 31, 2018 | -4,559.51% |
| Sep 30, 2018 | -557.97% |
| Jun 30, 2018 | -317.46% |
| Mar 31, 2018 | -201.44% |
| Dec 31, 2017 | -155.73% |
| Sep 30, 2017 | -119.11% |
| Jun 30, 2017 | -104.61% |
API Access
Protagenic Therapeutics, Inc.\new Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();